COVID-19

DataMeds AI’s Corexa Pharmacy Launches Tollo Health’s Tollovid(R) and Galactovid(TM)

Launch targets acute viral infection and Long COVID markets through www.CorexaRx.com/Store TAMPA, FL / ACCESS Newswire / July 31, 2026…

1 day ago

Hemostemix Closes Second Tranche of Private Placement and Obtains Extension to August 14, 2026

Calgary, Alberta--(Newsfile Corp. - July 30, 2026) - Hemostemix Inc.  (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is pleased…

2 days ago

Hemostemix’ Longevity Phase I Clinical Trial Leveraging VesCell(TM)’s Excellent Results

Calgary, Alberta--(Newsfile Corp. - July 28, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),…

4 days ago

NanoViricides Awaits Approval from DR Congo Regulatory Agency for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola, Financing Completed to Support the Trial

SHELTON, CT / ACCESS Newswire / July 28, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader…

4 days ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant appreciation of the Swiss franc

Group sales were +6% at constant exchange rates (CER)1, -2% when reported in CHF and +8% in USD2, in the…

1 week ago

ENT Experts in Philadelphia Share Preventive Tips for Reducing Sinus and Ear Issues During Flu Season

Becker ENT & Allergy shares preventive guidance for managing seasonal respiratory illness and protecting sinus and ear health. PHILADELPHIA, PA…

1 week ago

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

SHELTON, CT / ACCESS Newswire / July 22, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader…

1 week ago

Apollo Neuroscience Announces Publication of Landmark Clinical Study Demonstrating Apollo Wearable Use Yields an Average of 46 More Minutes of Sleep Per Night

Clinical study of 475,000 nights of sleep data across 935 people over 3 years found Apollo use was associated with…

2 weeks ago

Coalition for Health AI (CHAI) Launches PULSE, a National Initiative to Help Public Health Agencies Responsibly Implement AI at Scale

2,000 public health practitioners will join dedicated communities of practice and cross-jurisdiction peer networks, through enterprise licenses donated by Anthropic…

2 weeks ago

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

All Eight ACOs Achieve Net Shared SavingsALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with…

3 weeks ago
Show more Posts